- Ongoing, recruitingTherapeutic use (Phase IV)
Cluster randomised trial of low molecular weight heparins - Directly through Epic
This study is looking at two common blood-thinning medicines, Tinzaparin and Dalteparin, given to patients in hospitals. Researchers want to see if one is safer regarding serious bleeding or death within 30 days.
For: Venous thromboembolismDenmark - AuthorisedTherapeutic exploratory (Phase II)
PALETTE - Adaptive platform trial for personalisation of sepsis treatment in children and adults: a multi-national, treatable traits-guided, adaptive, exploratory, bayesian basket trial
This study is looking for better ways to treat sepsis in adults. It's testing several existing medicines to see if any work well for different types of sepsis. The main goals are to improve survival and help patients recover without needing machines to support their bodies.
For: SepsisFrance